Compound Planning Inc. Purchases 1,812 Shares of Intuitive Surgical, Inc. $ISRG

Compound Planning Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 77.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,149 shares of the medical equipment provider’s stock after acquiring an additional 1,812 shares during the period. Compound Planning Inc.’s holdings in Intuitive Surgical were worth $2,055,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its stake in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. grew its holdings in Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the period. Wellington Management Group LLP grew its position in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the first quarter worth about $1,715,899,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,839 shares of company stock worth $7,896,972. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. Citigroup reaffirmed a “buy” rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. BTIG Research increased their price target on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Finally, Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Trading Up 1.3%

Shares of ISRG stock opened at $476.16 on Friday. The stock has a 50 day simple moving average of $504.42 and a 200-day simple moving average of $522.06. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market cap of $170.69 billion, a price-to-earnings ratio of 66.41, a price-to-earnings-growth ratio of 4.92 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the prior year, the firm posted $1.78 EPS. The company’s revenue was up 21.4% compared to the same quarter last year. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.